BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30082640)

  • 1. Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation.
    Chiesa E; Pisani S; Colzani B; Dorati R; Conti B; Modena T; Braekmans K; Genta I
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30082640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
    Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
    Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vehicle for local protein delivery to the inner ear: injectable and biodegradable thermosensitive hydrogel loaded with PLGA nanoparticles.
    Dai J; Long W; Liang Z; Wen L; Yang F; Chen G
    Drug Dev Ind Pharm; 2018 Jan; 44(1):89-98. PubMed ID: 28851247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
    Chronopoulou L; Massimi M; Giardi MF; Cametti C; Devirgiliis LC; Dentini M; Palocci C
    Colloids Surf B Biointerfaces; 2013 Mar; 103():310-7. PubMed ID: 23261553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
    S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
    Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
    J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dexamethasone-loaded poly(lactic-co-glycolic acid) microsphere/poly(vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors.
    Wang Y; Vaddiraju S; Qiang L; Xu X; Papadimitrakopoulos F; Burgess DJ
    J Diabetes Sci Technol; 2012 Nov; 6(6):1445-53. PubMed ID: 23294792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
    Gullotti E; Park J; Yeo Y
    Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone-loaded biopolymeric nanoparticles promote gingival fibroblasts differentiation.
    Chronopoulou L; Amalfitano A; Palocci C; Nocca G; Callà C; Arcovito A
    Biotechnol Prog; 2015; 31(5):1381-7. PubMed ID: 26146812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint.
    Kim SR; Ho MJ; Lee E; Lee JW; Choi YW; Kang MJ
    Int J Nanomedicine; 2015; 10():5263-71. PubMed ID: 26345227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.